Joseph A. Sowell III - Dec 29, 2021 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP; Chief Development Officer
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Dec 29, 2021
Transactions value $: -$3,723,041
Form type: 4
Date filed: 1/3/2022, 05:38 PM
Next filing: Jan 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Options Exercise	$1.59M	+42.8K	+345.96%	$37.18^*	55.1K	Dec 29, 2021	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$5.31M	-20.6K	-37.29%	$258.49	34.6K	Dec 29, 2021	Direct	F1
holding	HCA	Common Stock						21.3K	Dec 29, 2021	By Trust (Reporting Person and Spouse, Trustees)
holding	HCA	Common Stock						8K	Dec 29, 2021	By Trust (Reporting Person, Trustee)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCA	Stock Appreciation Right	Options Exercise	$0	-42.8K	-100%	$0.00^*	0	Dec 29, 2021	Common Stock	42.8K	$37.18	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.